Pulsenmore Ltd. (TLV:PULS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 361.00
-16.80 (-4.45%)
Feb 20, 2025, 5:24 PM IDT
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 181.73 million as of February 21, 2025. Its market cap has decreased by -42.21% in one year.
Market Cap
181.73M
Enterprise Value
64.05M
Revenue
8.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
361.00
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 181.73M, a decrease of -77.14%. That is a compound annual growth rate of -32.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 181.73M | -27.78% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 68.37B |
| Danel (Adir Yeoshua) | 2.53B |
| Kamada | 1.57B |
| Bait Bakfar | 1.09B |
| Novolog (Pharm-Up 1966) | 907.03M |
| Ilex Medical | 800.59M |
| BrainsWay | 762.81M |
| SofWave Medical | 597.96M |